A detailed history of Oak Ridge Investments LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Oak Ridge Investments LLC holds 15,135 shares of BPMC stock, worth $1.36 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
15,135
Previous 15,744 3.87%
Holding current value
$1.36 Million
Previous $1.7 Million 17.51%
% of portfolio
0.12%
Previous 0.16%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$84.1 - $120.5 $51,216 - $73,384
-609 Reduced 3.87%
15,135 $1.4 Million
Q2 2024

Jul 16, 2024

BUY
$85.18 - $108.78 $302,814 - $386,712
3,555 Added 29.17%
15,744 $1.7 Million
Q1 2024

May 01, 2024

BUY
$73.17 - $99.79 $5,268 - $7,184
72 Added 0.59%
12,189 $1.16 Million
Q4 2023

Jan 16, 2024

SELL
$43.96 - $92.84 $75,127 - $158,663
-1,709 Reduced 12.36%
12,117 $1.12 Million
Q3 2023

Oct 30, 2023

SELL
$46.9 - $66.0 $20,964 - $29,502
-447 Reduced 3.13%
13,826 $694,000
Q2 2023

Aug 07, 2023

SELL
$42.2 - $66.37 $20,678 - $32,521
-490 Reduced 3.32%
14,273 $902,000
Q1 2023

Apr 14, 2023

SELL
$37.97 - $50.0 $16,782 - $22,100
-442 Reduced 2.91%
14,763 $664,000
Q4 2022

Jan 24, 2023

SELL
$41.06 - $66.48 $35,393 - $57,305
-862 Reduced 5.37%
15,205 $0
Q3 2022

Nov 08, 2022

BUY
$49.93 - $77.7 $9,636 - $14,996
193 Added 1.22%
16,067 $1.06 Million
Q2 2022

Jul 28, 2022

SELL
$45.23 - $70.15 $56,537 - $87,687
-1,250 Reduced 7.3%
15,874 $802,000
Q1 2022

Apr 22, 2022

SELL
$54.1 - $110.08 $529,098 - $1.08 Million
-9,780 Reduced 36.35%
17,124 $1.09 Million
Q4 2021

Feb 01, 2022

SELL
$94.25 - $115.99 $41,941 - $51,615
-445 Reduced 1.63%
26,904 $2.88 Million
Q3 2021

Nov 05, 2021

SELL
$80.98 - $109.47 $50,855 - $68,747
-628 Reduced 2.24%
27,349 $2.81 Million
Q2 2021

Jul 30, 2021

SELL
$82.78 - $101.0 $150,245 - $183,315
-1,815 Reduced 6.09%
27,977 $2.46 Million
Q1 2021

May 12, 2021

SELL
$90.71 - $108.28 $19.5 Million - $23.3 Million
-215,254 Reduced 87.84%
29,792 $2.9 Million
Q1 2021

May 04, 2021

BUY
$90.71 - $108.28 $19.4 Million - $23.2 Million
213,862 Added 685.81%
245,046 $23.8 Million
Q4 2020

Feb 03, 2021

SELL
$92.08 - $124.48 $682,128 - $922,147
-7,408 Reduced 19.2%
31,184 $3.5 Million
Q3 2020

Nov 12, 2020

SELL
$66.45 - $92.7 $194,233 - $270,962
-2,923 Reduced 7.04%
38,592 $3.58 Million
Q2 2020

Aug 05, 2020

SELL
$57.09 - $79.27 $213,459 - $296,390
-3,739 Reduced 8.26%
41,515 $3.24 Million
Q1 2020

May 13, 2020

SELL
$48.11 - $82.22 $98,192 - $167,811
-2,041 Reduced 4.32%
45,254 $2.65 Million
Q4 2019

Feb 05, 2020

SELL
$66.73 - $82.59 $591,161 - $731,664
-8,859 Reduced 15.78%
47,295 $3.79 Million
Q3 2019

Nov 07, 2019

BUY
$72.9 - $101.41 $1.53 Million - $2.13 Million
21,020 Added 59.83%
56,154 $4.13 Million
Q2 2019

Aug 14, 2019

BUY
$73.54 - $97.8 $2.58 Million - $3.44 Million
35,134 New
35,134 $3.32 Million

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.38B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.